Click Here for 5% Off Your First Aladdin Purchase!

AZD3778 , CAS No.1032129-23-9, Antagonist of CCR3;Antagonist of H 1 receptor;Channel blocker of K v11.1

  • Moligand™
Item Number
A607865
Grouped product items
SKUSizeAvailabilityPrice Qty
A607865-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,000.90
A607865-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,000.90

Basic Description

SynonymsAZD3778|AZD-3778|9BC2MUG4A8|UNII-9BC2MUG4A8|CHEMBL2158814|AZD-3778 [WHO-DD]|485391-80-8|(1,4'-Bipiperidine)-1'-carboxamide, 4-(3,4-dichlorophenoxy)-N-((4-methylphenyl)sulfonyl)-|4-(3,4-Dichlorophenoxy)-N-((4-methylphenyl)sulfonyl)(1,4'-bipiperidine)-1'-ca
GradeMoligand™
Action TypeANTAGONIST, CHANNEL BLOCKER
Mechanism of actionAntagonist of CCR3;Antagonist of H 1 receptor;Channel blocker of K v11.1

Associated Targets

CCR3 Tchem C-C chemokine receptor type 3 5 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HRH1 Tclin Histamine H1 receptor 4 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

KCNH2 Tclin Potassium voltage-gated channel subfamily H member 2 1 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 4-[4-(3,4-dichlorophenoxy)piperidin-1-yl]-N-(4-methylphenyl)sulfonylpiperidine-1-carboxamide
INCHI InChI=1S/C24H29Cl2N3O4S/c1-17-2-5-21(6-3-17)34(31,32)27-24(30)29-12-8-18(9-13-29)28-14-10-19(11-15-28)33-20-4-7-22(25)23(26)16-20/h2-7,16,18-19H,8-15H2,1H3,(H,27,30)
InChi Key QVLZVRFIGXNZMN-UHFFFAOYSA-N
Canonical SMILES Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl
Isomeric SMILES CC1=CC=C(C=C1)S(=O)(=O)NC(=O)N2CCC(CC2)N3CCC(CC3)OC4=CC(=C(C=C4)Cl)Cl
PubChem CID 11753159

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

References

1. Cook D, Brown D, Alexander R, March R, Morgan P, Satterthwaite G, Pangalos MN.  (2014)  Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework..  Nat Rev Drug Discov,  13  (6): (419-31).  [PMID:24833294]

Solution Calculators